Literature DB >> 4554035

The fate of riboflavin in the mammal.

D B McCormick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4554035     DOI: 10.1111/j.1753-4887.1972.tb03991.x

Source DB:  PubMed          Journal:  Nutr Rev        ISSN: 0029-6643            Impact factor:   7.110


× No keyword cloud information.
  5 in total

Review 1.  Improving the safety of whole blood-derived transfusion products with a riboflavin-based pathogen reduction technology.

Authors:  Susan Yonemura; Suzann Doane; Shawn Keil; Raymond Goodrich; Heather Pidcoke; Marcia Cardoso
Journal:  Blood Transfus       Date:  2017-05-11       Impact factor: 3.443

Review 2.  Riboflavin in Neurological Diseases: A Narrative Review.

Authors:  Domenico Plantone; Matteo Pardini; Giuseppe Rinaldi
Journal:  Clin Drug Investig       Date:  2021-04-22       Impact factor: 2.859

3.  Riboflavin deficiency leads to irreversible cellular changes in the RPE and disrupts retinal function through alterations in cellular metabolic homeostasis.

Authors:  Tirthankar Sinha; Larissa Ikelle; Mustafa S Makia; Ryan Crane; Xue Zhao; Mashal Kakakhel; Muayyad R Al-Ubaidi; Muna I Naash
Journal:  Redox Biol       Date:  2022-06-16       Impact factor: 10.787

4.  Flavin homeostasis in the mouse retina during aging and degeneration.

Authors:  Tirthankar Sinha; Mustafa Makia; Jianhai Du; Muna I Naash; Muayyad R Al-Ubaidi
Journal:  J Nutr Biochem       Date:  2018-09-15       Impact factor: 6.048

5.  Mitochondrial and Peroxisomal Alterations Contribute to Energy Dysmetabolism in Riboflavin Transporter Deficiency.

Authors:  Fiorella Colasuonno; Alessia Niceforo; Chiara Marioli; Anna Fracassi; Fabrizia Stregapede; Keith Massey; Marco Tartaglia; Enrico Bertini; Claudia Compagnucci; Sandra Moreno
Journal:  Oxid Med Cell Longev       Date:  2020-08-12       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.